408
Participants
Start Date
September 6, 2022
Primary Completion Date
November 21, 2024
Study Completion Date
December 21, 2024
AXS-05
AXS-05 tablets, taken twice daily
Placebo
Placebo tablets, taken twice daily
Clinical Research Site, Staten Island
Clinical Research Site, Brooklyn
Clinical Research Site, Woodmere
Clinical Research Site, New Windsor
Clinical Research Site, Arlington
Clinical Research Site, Charlotte
Clinical Research Site, Hickory
Clinical Research Site, College Park
Clinical Research Site, Augusta
Clinical Research Site, Columbus
Clinical Research Site, Orlando
Clinical Research Site, Hialeah
Clinical Research Site, Miami Gardens
Clinical Research Site, Miami Lakes
Clinical Research Site, Hollywood
Clinical Research Site, Pembroke Pines
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Miami
Clinical Research Site, Green Acres
Clinical Research Site, Brandon
Clinical Research Site, Tampa
Clinical Research Site, Tampa
Clinical Research Site, Bonita Springs
Clinical Research Site, Kissimmee
Clinical Research Site, Middleburg Heights
Clinical Research Site, Troy
Clinical Research Site, Rochester Hills
Clinical Research Site, Flint
Clinical Research Site, Chesterfield
Clinical Research Site, Wichita
Clinical Research Site, Marrero
Clinical Research Site, Mesquite
Clinical Research Site, Cypress
Clinical Research Site, Sugarland
Clinical Research Site, San Antonio
Clinical Research Site, Austin
Clinical Research Site, Tempe
Clinical Research Site, Peoria
Clinical Research Site, Tucson
Clinical Research Site, Los Alamitos
Clinical Research Site, Long Beach
Clinical Research Site, Canoga Park
Clinical Research Site, West Covina
Clinical Research Site, Walnut Creek
Clinical Research Site, Braintree
Clinical Research Site, Berlin
Clinical Research Site, Toms River
Clinical Research Site, Rutland
Clinical Research Site, Bayamón
Clinical Research Site, San Juan
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY